State office awards Ft 13.7 bln in R+D grants

Pharma

Hungary’s National Research and Technology Office (NKTH) has awarded a combined Ft 13.7 billion in R+D grants to 27 applicants, Hungary’s R+D minister Károly Molnár announced at a press conference in Budapest on Monday.

The 27 winners -- who will contribute an additional Ft 4.5 billion to R+D projects -- were picked from 136 applicants. Among the winners was a consortium led by drug maker Richter and including the Semmelweis University and the Zoltán Bay Applied Research Foundation. The consortium won a Ft 1 billion grant to research nanotechnology in the field of medicine.

Richter will contribute Ft 300 million from its own resources to the project, which it aims to use to develop and start producing a generic version of the drug Doxil, a liposome-encapsulated dosage form of doxorubicin, Richter CEO Erik Bogsch said. Richter hopes to introduce the drug in four years, he added. Bogsch said he could not say how much revenue the drug would generate when asked by MTI.

A consortium led by vehicle maker Rába won a Ft 894 million grant to develop integrated vehicle parts and technology. Rába will contribute Ft 300 million to the project. A third winner introduced by NKTH was Experimetria, which won a Ft 400 million grant to develop a heart monitor for patients under extreme stress. NKTH has Ft 30 billion to award for R+D grants this year. It will call a second tender for the money on September 15. Last year NKTH awarded R+D grants worth a combined Ft 20 billion to 55 applicants. (MTI-Econews)

ADVERTISEMENT

Business confidence improves as consumer sentiment worsens Analysis

Business confidence improves as consumer sentiment worsens

Meeting called to address Pegasus spyware lacks quorum  Parliament

Meeting called to address Pegasus spyware lacks quorum 

Skanska commercial dev unit names new EVP of operations Hung... Appointments

Skanska commercial dev unit names new EVP of operations Hung...

Zsa Zsa Gabor's ashes buried in Budapest City

Zsa Zsa Gabor's ashes buried in Budapest

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.